1. Home
  2. TCI vs PRTA Comparison

TCI vs PRTA Comparison

Compare TCI & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCI

Transcontinental Realty Investors Inc.

HOLD

Current Price

$52.73

Market Cap

455.6M

Sector

Finance

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.72

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
PRTA
Founded
1983
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
455.6M
538.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TCI
PRTA
Price
$52.73
$9.72
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$18.86
AVG Volume (30 Days)
2.2K
517.2K
Earning Date
11-06-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
75.87
N/A
EPS
0.65
N/A
Revenue
$48,675,000.00
$11,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,183.79
P/E Ratio
$81.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.50
$4.32
52 Week High
$59.65
$16.67

Technical Indicators

Market Signals
Indicator
TCI
PRTA
Relative Strength Index (RSI) 50.59 53.04
Support Level $49.91 $8.65
Resistance Level $53.94 $10.53
Average True Range (ATR) 1.72 0.44
MACD -0.45 0.13
Stochastic Oscillator 34.95 60.64

Price Performance

Historical Comparison
TCI
PRTA

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: